@article{1dad4cc3383a4662b0ac44d7ea2761c1,
title = "Do behavioral treatments work for migraine prevention?",
keywords = "behavior change techniques, health behavior, migraine, psychological factors",
author = "Seng, {Elizabeth K.} and Lipton, {Richard B.}",
note = "Funding Information: Elizabeth K. Seng, Ph.D., has consulted or served on an advisory board for GlaxoSmithKline, Click Therapeutics, and Abbvie and received research funding from the NINDS (NS096107 PI: Seng), NCCIH (R01AT011005‐01A1 MPIs: Seng and Shallcross), and the Veteran{\textquoteright}s Health Administration (the Headache Center of Excellence Research and Evaluation Center and VA HSR&D, IRP 20‐002 PI: Damush). Richard B. Lipton, M.D., has received research support from the National Institutes of Health, the FDA, and the National Headache Foundation. He serves as consultant, advisory board member, or has received honoraria or research support from AbbVie/Allergan, Amgen, Biohaven, Dr. Reddy{\textquoteright}s Laboratories (Promius), electroCore, Eli Lilly, GlaxoSmithKline, Lilly, Lundbeck, Merck, Novartis, Teva, Vector, and Vedanta Research. He receives royalties from , 8th edition (Oxford University Press, 2009), and Informa. He holds stock/options in Biohaven, CntrlM, and Mainistee. Wolff{\textquoteright}s Headache",
year = "2022",
month = apr,
doi = "10.1111/head.14290",
language = "English (US)",
volume = "62",
pages = "402--404",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "4",
}